Stay updated on Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page shows revision v3.6.6 replacing the previous v3.6.5, indicating a small update to the page version. The update does not alter study details or other substantive content.
    Difference
    0.1%
    Check dated 2026-08-30T22:30:32.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, indicating a minor backend or content-management update to the page. No substantive changes to the study details or user-facing information are evident.
    Difference
    0.1%
    Check dated 2026-08-09T09:31:22.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a software update; it does not modify the study text, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-25T18:13:34.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a minor build/template update that does not modify study content.
    Difference
    0.1%
    Check dated 2026-07-04T13:23:18.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.2 instead of v3.6.0, indicating a newer build of the site. This update records the release version displayed for the page.
    Difference
    0.1%
    Check dated 2026-06-27T07:36:47.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    The study record now shows recruitment has ended with a note 'No longer looking for participants.' New help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the Intervention/Treatment label formatting was updated.
    Difference
    0.6%
    Check dated 2026-06-13T05:09:10.000Z thumbnail image

Stay in the know with updates to Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.